ANP ASX Chart
Snapshot
Antisense Therapeutics Limited (ANP) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a range of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly. The group has focus on advancing its antisense oligonucleotide products under development.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | -43.83% |
vs ASX 200 (1yr) | -52.21% |
Key Fundamentals
Shares Issued | |
Sector | Healthcare |
Similar Companies | PCK / EYE / MVP |
EPS | $0.00 |
DPS | $0.00 |
Book Value Per Share | $0.00 |
Broker Consensus
Please see the Broker Consensus page.
Latest Antisense Therapeutics Ltd News
Announcements
Corporate Overview
Corporate Details
Head Office | Toorak VIC 3142 |
Website | www.antisense.com.au |
Registry | BoardRoom |
Auditor | Ernst and Young |
Date Listed | 20 Dec 2001 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
21/02/2024 | Report (Interim) |
23/08/2024 | Report (Prelim) |
23/08/2024 | Report (Annual) |
Former Company Names
- Antisense Therapeutics Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
ANP directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of ANP directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Platinum Investment Management Limited | 16/10/2023 | 110,755,158 | 12.29 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
24-07-23 | Platinum Investment Management Limited | 111,483,140 | -- | 13.33 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
16-10-23 | Platinum Investment Management Limited | 727,982 | 13.3 | 12.3 |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.059 | 30 June |
2022 | $0.076 | 30 June |
2021 | $0.195 | 30 June |
2020 | $0.074 | 30 June |
2019 | $0.045 | 28 June |
2018 | $0.025 | 29 June |
2017 | $0.033 | 28 June |
2016 | $0.031 | 28 June |
2015 | $0.115 | 30 June |
2014 | $0.140 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.